AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 1 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $11,445,000 | -79.3% | 489,105 | -73.2% | 0.09% | -76.5% |
Q4 2015 | $55,159,000 | -26.4% | 1,827,052 | -3.2% | 0.37% | -30.1% |
Q3 2015 | $74,967,000 | -18.9% | 1,886,905 | +41.0% | 0.53% | -5.9% |
Q2 2015 | $92,447,000 | +15.6% | 1,338,646 | -8.5% | 0.56% | +22.3% |
Q1 2015 | $79,989,000 | +51.8% | 1,463,390 | +18.3% | 0.46% | +48.7% |
Q4 2014 | $52,708,000 | +34.1% | 1,236,690 | +0.4% | 0.31% | +29.2% |
Q3 2014 | $39,304,000 | – | 1,231,720 | – | 0.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 520,000 | $15,699,000 | 7.39% |
Palo Alto Investors LP | 2,835,792 | $85,613,000 | 4.76% |
Opaleye Management Inc. | 150,000 | $4,529,000 | 1.89% |
Engaged Capital LLC | 61,425 | $1,854,000 | 1.15% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 91,400 | $2,759,000 | 1.14% |
Endurant Capital Management LP | 111,180 | $3,357,000 | 1.12% |
AlphaOne Investment Services, LLC | 86,817 | $2,621,000 | 0.94% |
ASHFORD CAPITAL MANAGEMENT INC | 127,625 | $3,853,000 | 0.91% |
ARDSLEY ADVISORY PARTNERS LP | 205,000 | $6,189,000 | 0.81% |
STELLIAM INVESTMENT MANAGEMENT, LP | 685,000 | $20,680,000 | 0.62% |